Literature DB >> 3057064

Idiopathic adulthood ductopenia. A cause of chronic cholestatic liver disease and biliary cirrhosis.

J Ludwig1, R H Wiesner, N F LaRusso.   

Abstract

We describe three adult patients who had chronic cholestatic liver disease associated with unexplained loss of interlobular bile ducts; two of these patients eventually required orthotopic liver transplantation. We have named this condition 'idiopathic adulthood ductopenia' because (1) the etiology is unknown, (2) the age of the patients may be the only distinguishing feature between this newly described condition and neonatal or infantile nonsyndromatic paucity of intrahepatic bile ducts, and (3) morphologic demonstration of ductopenia is an indispensable finding. Our three patients, all males, had a negative drug history, absence of antimitochondrial antibodies, normal cholangiographic findings, and no evidence of inflammatory bowel disease. Idiopathic adulthood ductopenia may be a representation of (1) late onset of infantile paucity of intrahepatic bile ducts, (2) destructive viral cholangitis, and (3) isolated small-duct primary sclerosing cholangitis - that is, 'pericholangitis' unassociated with inflammatory bowel disease.

Entities:  

Mesh:

Year:  1988        PMID: 3057064     DOI: 10.1016/s0168-8278(88)80482-3

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  23 in total

1.  Idiopathic adulthood ductopenia: long-term follow-up after liver transplantation.

Authors:  R Rios; J I Herrero; J Quiroga; B Sangro; I Sola; F Pardo; J A Cienfuegos; M Herraiz; J Prieto
Journal:  Dig Dis Sci       Date:  2001-07       Impact factor: 3.199

2.  Hepatitis C and bile duct loss.

Authors:  R D Goldin; N K Patel; H C Thomas
Journal:  J Clin Pathol       Date:  1996-10       Impact factor: 3.411

Review 3.  Autoimmune hepatitis. Evolving concepts and treatment strategies.

Authors:  A J Czaja
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

Review 4.  Primary sclerosing cholangitis.

Authors:  Y Ueno; N F LaRusso
Journal:  J Gastroenterol       Date:  1994-08       Impact factor: 7.527

5.  Vanishing bile duct syndrome in human immunodeficiency virus: nevirapine hepatotoxicity revisited.

Authors:  Rajan Kochar; Moises I Nevah; Frank J Lukens; Michael B Fallon; Victor I Machicao
Journal:  World J Gastroenterol       Date:  2010-07-14       Impact factor: 5.742

6.  Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis.

Authors:  E Björnsson; K M Boberg; S Cullen; K Fleming; O P Clausen; O Fausa; E Schrumpf; R W Chapman
Journal:  Gut       Date:  2002-11       Impact factor: 23.059

7.  Vanishing bile duct syndrome in human immunodeficiency virus infected adults: a report of two cases.

Authors:  Ana Paula Oppenheimer; Christopher Koh; Mary McLaughlin; John C Williamson; Thomas D Norton; Jennifer Laudadio; Theo Heller; David E Kleiner; Kevin P High; Caryn G Morse
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

8.  Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis.

Authors:  P Michieletti; I R Wanless; A Katz; P J Scheuer; S J Yeaman; M F Bassendine; J M Palmer; E J Heathcote
Journal:  Gut       Date:  1994-02       Impact factor: 23.059

9.  Mycophenolate mofetil for drug-induced vanishing bile duct syndrome.

Authors:  S-Simona Jakab; A-Brian West; Dennis-M Meighan; Robert S Brown; William-B Hale
Journal:  World J Gastroenterol       Date:  2007-12-07       Impact factor: 5.742

10.  A case of idiopathic adulthood ductopenia.

Authors:  Byeong Chool Park; Seon Mee Park; Eun Young Choi; Hee Bok Chae; Se Jin Yoon; Rohyun Sung; Sung Koo Lee
Journal:  Korean J Intern Med       Date:  2009-08-26       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.